Subscribe To
Mersana Therapeutics Provides Statement About SVB
CAMBRIDGE, Mass., March 10, 2023 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today provided an update about its capital resources. A de minimis amount of Mersana’s capital is currently held […] The post Mersana Therapeutics Provides Statement About SVB appeared first on ForexTV...
Read More
Posted: Mar 11 2023, 00:10
Author Name: forextv
Views: 082184